ArticleBMJ open2020

Rationale and design of a prospective, observational, multicentre study on the safety and efficacy of apixaban for the prevention of thromboembolism in adults with congenital heart disease and atrial arrhythmias: the PROTECT-AR study.

Anastasios Kartas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.